Erika Hamilton/LinkedIn
Jun 1, 2025, 04:53
Erika Hamilton: Highlights from Me at Day 2 of ASCO25
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute, posted on LinkedIn:
“Highlights for me Day 2 at ASCO25?
8:00-9:30 am CST, Hall D1.
Special Clinical Science Symposium: the Future of Cancer Detection is Coming
- 2 abstracts using ctDNA to detect cancer early (Matthew Margolis, Dax Kurbegov).
- experts weigh in on the different technology and available tests (Maximilian Diehn).
- future clinical utility of these assays.
- hear from a patient about the promise…and pitfalls Jane Perlmutter.
1:15-4:15pm CST, Hall B1
Oral Abstract Session: Metastatic Breast Cancer.
- ASCENT04 sacituzumab + pembro for 1L TNBC PDL-1+
- novel endocrine agents (VERITAC-2 [COI, I am presenting], and PROs from hashtag#imlunestrant EMBER-3) Giuseppe Curigliano.
- PIK3 inhibitor x 2 varieties.
- oral paclitaxel.
- DB-06 biomarkers Rebecca Dent.
4:45-6:00pm CST, S102
Education Session: Artificial Intelligence in the Clinic
- this is here NOW folks and increasing.
- ambient listening technology in clinic.
- scaling AI to all practices.”
More posts featuring Erika Hamilton.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 09:04
Jun 4, 2025, 08:53
Jun 4, 2025, 08:42
Jun 4, 2025, 07:55
Jun 4, 2025, 07:50